Cyclerion Therapeutics(CYCN.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Cyclerion Therapeutics
CYCN.US
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
1.813 T
CYCN.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
D
BiotechnologyIndustry
Industry Ranking307/386
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-67.77%E
    • Profit Margin-264.73%E
    • Gross Margin0.00%E
  • Growth ScoreD
    • Revenue YoY-4.23%D
    • Net Profit YoY-79.21%E
    • Total Assets YoY-13.63%E
    • Net Assets YoY-22.65%E
  • Cash ScoreD
    • Cash Flow Margin66.76%C
    • OCF YoY-4.23%D
  • Operating ScoreD
    • Turnover0.22D
  • Debt ScoreA
    • Gearing Ratio20.15%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    14:55 ETAre OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?

    prnewswire·
    US
    OGN
    0.00%
    US
    TBRG
    0.00%
    US
    CYCN
    -0.66%
    prnewswire·
    US
    OGN
    0.00%
    US
    TBRG
    0.00%
    US
    CYCN
    -0.66%

    15:30 ETAre UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?

    prnewswire·
    US
    NSA
    +0.34%
    US
    ULYX
    0.00%
    US
    UNF
    -0.59%
    prnewswire·
    US
    NSA
    +0.34%
    US
    ULYX
    0.00%
    US
    UNF
    -0.59%

    14:15 ET$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN

    prnewswire·
    US
    CYCN
    -0.66%
    US
    CWAN
    -0.12%
    US
    THR
    -0.98%
    prnewswire·
    US
    CYCN
    -0.66%
    US
    CWAN
    -0.12%
    US
    THR
    -0.98%

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    benzinga_article·
    US
    PFSA
    -7.31%
    US
    KPRX
    +0.40%
    US
    CUPR
    -3.21%
    benzinga_article·
    US
    PFSA
    -7.31%
    US
    KPRX
    +0.40%
    US
    CUPR
    -3.21%

    12 Health Care Stocks Moving In Monday's Pre-Market Session

    benzinga_article·
    US
    ANVS
    -5.37%
    US
    CYCN
    -0.66%
    US
    XPH
    +0.07%
    benzinga_article·
    US
    ANVS
    -5.37%
    US
    CYCN
    -0.66%
    US
    XPH
    +0.07%
    © 2026 Longbridge｜Disclaimer